(Q33411909)

English

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 s

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 s (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kaoru Kubota

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Toyoaki Hida

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Satoshi Ishikura

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Junki Mizusawa

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Makoto Nishio

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Masaaki Kawahara

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Akira Yokoyama

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Fumio Imamura

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Koji Takeda

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Shunichi Negoro

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Masao Harada

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hiroaki Okamoto

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nobuyuki Yamamoto

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Tetsu Shinkai

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hiroshi Sakai

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kaoru Matsui

16

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kazuhiko Nakagawa

17

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Taro Shibata

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nagahiro Saijo

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Tomohide Tamura

20

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Japan Clinical Oncology Group

21

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

3 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

106-113

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nonfilter and filter cigarette consumption and the incidence of lung cancer by histological type in Japan and the United States: analysis of 30-year data from population-based cancer registries

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology G

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Early palliative care for patients with metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer [seecomments].

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970511-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(13)70511-4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

release_pzha2ynxavdunm6ldp7b6wt7ie

1 reference

https://api.fatcat.wiki/v0/release/pzha2ynxavdunm6ldp7b6wt7ie

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33411909&oldid=1835816281"